InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,859.71
(
0.77%
)
US TECH 100
19,890.42
(
0.79%
)
Dow Jones
43,056.10
(
0.45%
)
Brent Oil
77.52
(
0.06%
)
Bitcoin
65,835.27
(
4.75%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jadite

Send PM Follow Ignore
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

jadite

Re: nutsyprofessor post# 18706

Friday, 07/27/2012 10:14:38 AM

Friday, July 27, 2012 10:14:38 AM

Post# of 26138
Prof,

Thanks for the recap!

ATRS management is more forthcoming with info than BPAX's (perhaps for reasons that cannot be disclosed). ATRS puts anticipated "mystery" drugs in their pipeline.

I think something happened that prompted them to add Libigel back. News is coming IMO.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up